about
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also con...
Read More
12.79
-0.62
(-4.62%)
43,000
XNAS Volume
XNAS 09 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
Polyrizon Ltd Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..